AbCellera Biologics Inc.

An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.

ABCL | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 150 W 4TH AVENUE, VANCOUVER
Website:: https://www.abcellera.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

AbCellera Biologics Inc. is a clinical-stage biotechnology company that discovers and develops antibody-based therapeutics. The company operates a proprietary, AI-powered drug discovery platform that integrates advanced technologies in biology, computation, and engineering. This full-stack platform is designed to search, decode, and analyze natural immune systems at high speed and scale to find novel antibodies for therapeutic development. AbCellera partners with pharmaceutical and biotech companies to advance a pipeline of first-in-class and best-in-class antibody programs across various therapeutic areas, including cancer and endocrinology. The platform supports the development of complex modalities, such as bispecifics and antibody-drug conjugates, for conditions with high unmet medical need.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all AbCellera Biologics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AbCellera Biologics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for AbCellera Biologics Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
BeyondSpring Inc. Develops innovative immuno-oncology cancer therapies, including a 'pipeline in a drug' asset.	United States of America	BYSI
bioAffinity Technologies, Inc. Develops noninvasive diagnostics for cancer, including an early lung cancer sputum test.	United States of America	BIAF
BIO-FD&C CO.,LTD. Develops plant cell-derived active ingredients for food, drug, and cosmetic industries.	South Korea	251120
BioNexus Gene Lab Corp Develops non-invasive, blood-based RNA tests for early cancer detection and risk assessment.	United States of America	BGLC
Biophytis S.A. Clinical-stage biotech developing drugs for age-related neuromuscular and retinal diseases.	France	ALBPS
BioSenic SA Developing ATO and cell therapies for autoimmune diseases and tissue regeneration.	Belgium	BIOS
BIOTECH Biotech group offering preclinical zebrafish testing & intein tech for human/animal health.	Spain	BST
BiotoxtechCo.,Ltd. A non-clinical CRO providing GLP-compliant safety and toxicity testing for diverse industries.	South Korea	086040
Bolt Biotherapeutics, Inc. Developing immunotherapies that use antibody conjugates to help the immune system destroy cancer.	United States of America	BOLT
Bonus BioGroup Ltd. Develops cell therapies and tissue products for bone grafts and inflammation repair.	Israel	BONS